SIGN UP
LOG IN
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Benzinga·11/08/2024 10:54:20
Listen to the news
Shares of Upstart Holdings, Inc. (NASDAQ:UPST) rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter financial results.
Upstart reported quarterly losses of seven cents per share which beat the analyst consensus estimate for losses of 15 cents. Quarterly revenue came in at $162.14 million which beat the analyst consensus estimate of $150.22 million and is an increase over sales of $134.55 million from the same period last year.
Upstart shares jumped 23.1% to $68.29 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- DevvStream Corp. (NASDAQ:DEVS) gained 370% to $4.85 in pre-market trading after dipping around 58% on Thursday.
- Tivic Health Systems, Inc. (NASDAQ:TIVC) rose 52.8% to $0.4010 in pre-market trading. Tivic Health® Systems will report financial results on Thursday, Nov, 14, after the closing bell.
- Doximity, Inc (NYSE:DOCS) shares surged 44.2% to $62.60 in pre-market trading following better-than-expected second-quarter financial results.
- Li-Cycle Holdings Corp. (NYSE:LICY) gained 41% to $5.09 in pre-market trading after posting upbeat quarterly results.
- Northann Corp. (NYSE:NCL) climbed 37.6% to $0.3089 in pre-market trading after jumping around 12% on Thursday.
- Innodata Inc. (NASDAQ:INOD) shares rose 36.4% to $33.20 in pre-market trading after the company reported better-than-expected third-quarter financial results.
- Nature’s Miracle Holding Inc. (NASDAQ:NMHI) gained 31.8% to $0.1953 in pre-market trading after jumping over 52% on Thursday.
- Five9, Inc. (NASDAQ:FIVN) gained 24.6% to $40.88 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued FY24 guidance above estimates.
- Lumentum Holdings Inc. (NASDAQ:LITE) gained 24.3% to $91.54 in pre-market trading after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates.
Losers
- ProPhase Labs, Inc. (NASDAQ:PRPH) shares tumbled 45.4% to $0.7800 in pre-market trading after the company announced the pricing of public offering of common stock.
- Evolent Health, Inc. (NYSE:EVH) shares fell 33.6% to $16.31 in pre-market trading after the company reported worse-than-expected third-quarter financial results.
- AtlasClear Holdings, Inc. (NYSE:ATCH) dipped 31.8% to $0.1910 in pre-market trading after jumping over 55% on Thursday.
- agilon health, inc. (NYSE:AGL) shares fell 29% to $1.98 in pre-market trading after the company reported worse-than-expected quarterly revenue results.
- Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) declined 26.6% to $5.75 in pre-market trading after the company reported worse-than-expected third-quarter financial results and cut its FY24 sales guidance.
- MDJM Ltd (NASDAQ:MDJH) shares dipped 22.4% to $0.1511 in pre-market trading after jumping 30% on Thursday.
- Earlyworks Co., Ltd (NASDAQ:ELWS) fell 17% to $5.60 in pre-market trading after surging over 10% on Thursday.
- Sweetgreen, Inc. (NYSE:SG) fell 15% to $35.87 in today's pre-market trading after the company reported worse-than-expected quarterly financial results.
- Redfin Corporation (NASDAQ:RDFN) fell 14.1% to $9.85 in pre-market trading after the company reported worse-than-expected third-quarter financial results.
- Wag! Group Co. (NYSE:PET) fell 13.8% to $0.5487 in pre-market trading. Wag! will report third quarter 2024 financial results before the opening bell on Wednesday, Nov. 13.
Now Read This:
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.